Market Cap | 1.10B | P/E | 7.97 | EPS this Y | -11.20% | Ern Qtrly Grth | 18.90% |
Income | 8.47M | Forward P/E | 8.39 | EPS next Y | 110.00% | 50D Avg Chg | 10.00% |
Sales | 1.5B | PEG | 1.50 | EPS past 5Y | 34.13% | 200D Avg Chg | 4.00% |
Dividend | 1.00% | Price/Book | 1.45 | EPS next 5Y | 10.00% | 52W High Chg | -11.00% |
Recommedations | 2.00 | Quick Ratio | 0.67 | Shares Outstanding | 26.71M | 52W Low Chg | 30.00% |
Insider Own | 3.19% | ROA | 0.70% | Shares Float | 25.88M | Beta | 1.69 |
Inst Own | 88.43% | ROE | 1.11% | Shares Shorted/Prior | 320.80K/268.05K | Price | 39.75 |
Gross Margin | 7.42% | Profit Margin | 0.57% | Avg. Volume | 152,700 | Target Price | 35.50 |
Oper. Margin | 12.56% | Earnings Date | Nov 1 | Volume | 100,549 | Change | -1.29% |
AdvanSix Inc. engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capran, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
Stifel | Buy | Apr 9, 24 |
Piper Sandler | Overweight | Nov 21, 23 |
Piper Sandler | Overweight | Oct 11, 23 |
Piper Sandler | Overweight | May 16, 23 |
Piper Sandler | Overweight | Apr 12, 23 |
Piper Sandler | Overweight | Oct 10, 22 |
Piper Sandler | Overweight | Aug 8, 22 |
Piper Sandler | Overweight | Mar 14, 22 |
Piper Sandler | Overweight | Nov 12, 21 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Kintiroglou Achilles B. | SVP, General Counsel SVP, General Counsel | Jan 02 | Sell | 30 | 500 | 15,000 | 27,099 | 01/02/24 |
Gramm Christopher | Controller Controller | Jun 16 | Sell | 35.97 | 1,000 | 35,970 | 34,744 | 06/16/23 |
Gramm Christopher | Controller Controller | Mar 16 | Sell | 35 | 1,000 | 35,000 | 37,744 | 03/16/23 |
Gramm Christopher | Controller Controller | Oct 17 | Sell | 32.55 | 1,000 | 32,550 | 34,954 | 10/18/22 |
Gramm Christopher | Controller Controller | Jun 15 | Sell | 38.95 | 1,000 | 38,950 | 38,765 | 06/16/22 |
Gramm Christopher | Controller Controller | Apr 18 | Sell | 50.55 | 1,000 | 50,550 | 40,765 | 04/18/22 |
Marberry Michael | Director Director | Feb 24 | Buy | 34.73 | 713 | 24,762 | 122,301 | 02/28/22 |